MarketsNotableSingle-sourceDeveloping
5.1
Nex Neo Tech Inc. Files 8-K Reporting Change in Control and Executive Leadership
SEC EDGAR 8-K FilingsLO·US·about 12 hours ago
MarketsSingle-sourceLow
2.0
Faeth Therapeutics reports executive or director departure via 8-K filing
Faeth Therapeutics filed an 8-K disclosing a change in leadership or board composition under Item 5.02. The specific individuals involved and the nature of the departure remain to be detailed in the full filing text.
Score Breakdown
Mosaic Score2.0
Confidence0.9
Significance0.1
Source credibility0.1
Related signals
8 foundMarketsSingle-source
2.0
Keros Therapeutics reports executive or director departure via 8-K filing
SEC EDGAR 8-K FilingsLO·US·1 day ago
MarketsSingle-source
2.0
Jerash Holdings (US), Inc. reports executive or director departure
SEC EDGAR 8-K FilingsLO·US·3 days ago
MarketsSingle-source
2.0
Ecominas Corp. files 8-K disclosing equity issuance and executive leadership changes
SEC EDGAR 8-K FilingsLO·US·2 days ago
MarketsSingle-source
2.0
Blusky AI Inc. files 8-K disclosing material agreement and executive leadership changes
SEC EDGAR 8-K FilingsLO·US·1 day ago
MarketsSingle-source
2.0
Corvus Pharmaceuticals reports executive or director departure via 8-K filing
SEC EDGAR 8-K FilingsLO·US·1 day ago
MarketsSingle-source
2.0
Hudson Acquisition I Corp. files 8-K regarding corporate governance and shareholder voting
SEC EDGAR 8-K FilingsLO·US·1 day ago
MarketsNotableSingle-sourceDeveloping
5.1
Kensington Capital Acquisition Corp. VI files 8-K regarding material definitive agreement
SEC EDGAR 8-K FilingsLO·US·1 day ago